Brivaracetam Patent Expiration
Brivaracetam is used for managing partial-onset seizures in patients with epilepsy aged 4 years and older. It was first introduced by Ucb Inc
Brivaracetam Patents
Given below is the list of patents protecting Brivaracetam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Briviact | US10729653 | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives | Apr 09, 2030 | Ucb Inc |
| Briviact | US6911461 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | Feb 21, 2026 | Ucb Inc |
| Briviact | US6784197 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
Feb 21, 2021
(Expired) | Ucb Inc |
| Briviact | US8492416 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
Feb 21, 2021
(Expired) | Ucb Inc |
Brivaracetam's Family Patents
Explore Our Curated Drug Screens
Brivaracetam Generic API Manufacturers
Several generic applications have been filed for Brivaracetam. The first generic version for Brivaracetam was by Sunshine Lake Pharma Co Ltd and was approved on Jun 9, 2022. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Jan 6, 2023.
Given below is the list of companies who have filed for Brivaracetam generic, along with the locations of their manufacturing plants worldwide.
1. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Brivaracetam. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Discontinued | ORAL | N/A | Jan 6, 2023 |
| 50MG | tablet | Discontinued | ORAL | N/A | Jan 6, 2023 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. LUPIN LTD
Lupin Ltd has filed for 5 different strengths of generic version for Brivaracetam. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
| 75MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
| 100MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
| 10MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
| 50MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 5 different strengths of generic version for Brivaracetam. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
| 25MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
| 50MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
| 75MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
| 100MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
Manufacturing Plant Locations New
Sunshine's manufacturing plants are situated in 6 countries - United States, Peru, India, Thailand, China, Mozambique. Given below are the details of these plant locations as well as the firm names of Sunshine as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||||||||||||||
| Peru |
| |||||||||||||||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||||||||||||||
| Thailand |
| |||||||||||||||||||||||||||||||||||||||||
| China |
| |||||||||||||||||||||||||||||||||||||||||
| Mozambique |
| |||||||||||||||||||||||||||||||||||||||||
4. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Brivaracetam. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
| 25MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
| 50MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
| 75MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
| 100MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |